New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 9, 2018 - Teva launched an AB-rated generic version of Salix Pharmaceuticals’ Uceris (budesonide) extended-release tablets.
Download PDF
Return to publications
